Compare · ALC vs LUCY
ALC vs LUCY
Side-by-side comparison of Alcon Inc. (ALC) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $33.27B, about 4532.7x LUCY ($7.3M).
- LUCY has been more active in the news (6 items in the past 4 weeks vs 3 for ALC).
- ALC has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Alcon Inc.
- Innovative Eyewear Inc.
- Price
- -
- -
- Market cap
- $33.27B
- $7.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2022
- News (4w)
- 3
- 6
- Recent ratings
- 25
- 0
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Latest ALC
- FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Barclays initiated coverage on Alcon with a new price target
- Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
- Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
- Alcon Prices EUR 500 Million Senior Notes Offering
- Alcon downgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- SEC Form SD filed by Alcon Inc.
Latest LUCY
- SEC Form 8-K filed by Innovative Eyewear Inc.
- SEC Form 8-K filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Launches Lucyd Aero
- Innovative Eyewear Reports Record Preliminary Q3 2026 Net Sales, Up 55% Year-Over-Year
- SEC Form DEF 14A filed by Innovative Eyewear Inc.
- SEC Form PRE 14A filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Exclusive Australia and New Zealand Distribution Partnership with Directed Electronics
- Innovative Eyewear, Inc. Announces Q3 Business Update
- Chief Financial Officer Gayle Oswald was granted 32,466 shares and sold $13,491 worth of shares (15,533 units at $0.87), increasing direct ownership by 591% to 19,798 units (SEC Form 4)
- Chief AI & Growth Officer Dabrowski Konrad sold $11,874 worth of shares (13,627 units at $0.87) and was granted 41,800 shares, increasing direct ownership by 220% to 40,977 units (SEC Form 4)